PRM16 - Cost of Acute Myocardial Infarction in Colombia (2014)

Abstract

To estimate Acute Myocardial Infarction (AMI) risk and cost of illness for Colombia During 2014 from third payer perspective. Data bases from the National Administrative Department of Statistics (DANE), Health system (SISPRO), tariff manual of medical, surgical and hospital procedures (SOAT) and the system of information of prices of medicines (SISMED) were integrated to evaluate the Incidence, mortality and cost (from a case base) of the AMI acute management (ER and ICU) during 2014.Incidence of AMI were estimated from the number of patients seen in the emergency department during 2014 (ICD I20 to I25), mortality from non-fetal Deaths of DANE; costs of care from the resources consumption reported on the Survey of management strategies in Acute Coronary Syndrome on the Access study and cost from SISMED and SOAT databases. During 2014, 10,643 people were treated at the emergency department with and AMI, concentrating 1.45 events by person (15,428 attentions by AMI). With an incidence of 4.8 x 10,000 inhabitants. The overall mortality rate for this entity was 10.1 x 100,000 inhabitants older than 18 year of age.The estimated costs of care (given the consumption risk from the Access Study) for the year 2014 were $ 13,883,087,744 COP or $ 5,675,021 USD (exchange rate adjusted to 17 December 2014). Despite public databases limitations, AMI was identify as a main budget agent for 2014, given a reported health expenditure for Colombia in 2014 of 7.2% of GDP, (54.54 billions), the AMI probably contributed with 0.03% of it, with an projected increase in 2017 to $ 16,783,161,956. There is expected that population aging, rice of cardiovascular diseases precursors (dyslipidemia, smoke, obesity, diabetes, etc.), associated cost of ambulatory and disability therapies, would increase this expenditure. To overcome limitations of this study, observational prospective design studies must be done.